2017-06-12 18:43:10 UTC

Freston Preview: Diagnostic and Therapeutic Potential of EVs

June 13, 2017

A look at sessions five and six of the 2017 Freston conference taking place in St. Paul, MN this September.

This week we wrap up our preview of the 2017 James W. Freston conference with a look at sessions five and six, which cover the diagnostic and therapeutic potential of extracellular vesicles (EVs).

In case you missed them, make sure to check out previews for sessions one, two, three and four. The 2017 conference will take place on Sept. 9 and 10, in St. Paul, MN.

Application: Diagnosis and Therapeutics
Sessions five and six will closely examine the clinical applications of EVs as diagnostic tools and their therapeutic potential for treating GI diseases. A few of the key questions that will be addressed during these sessions include:

  • What are the roles of EV RNA in disease diagnosis?
  • Can EV RNA be detected with adequate sensitivity and reproducibility to serve as diagnostic assays?
  • What are the roles of EVs and their cargo for molecular diagnosis of liver inflammation, fibrosis and metabolic stress?

To view the program in its entirety and to register, visit the conference web page.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

A word from Co-Chair Nicholas F. LaRusso, MD, AGAF